Table 3 Prognostic factors for ESRD in PRS patients.
From: Clinical characteristics and prognosis of pulmonary renal syndrome in West China
ESRD (unadjusted) | |||
|---|---|---|---|
OR (95% CI) | SE | P value | |
Sex | 1.07 (0.34–3.33) | 0.62 | 0.91 |
Age | 1.00 (0.96–1.03) | 0.02 | 0.76 |
Duration of prodromal illness | 1.11 (0.92–1.35) | 0.11 | 0.28 |
Fever | 0.72 (0.12–4.37) | 0.66 | 0.72 |
Hemoptysis | 1.74 (0.50–6.09) | 1.11 | 0.39 |
Respiratory failure | 0.70 (0.22–2.27) | 0.42 | 0.56 |
PAH | 1.18 (0.34–4.16) | 0.75 | 0.8 |
Initial hemodialysis | 4.93 (1.44–16.88) | 3.1 | 0.01 |
Mechanical ventilation | 0.37 (0.07–1.98) | 0.31 | 0.24 |
ANCA positive | 0.63 (0.11–3.49) | 0.55 | 0.6 |
anti-GBM antibody positive | 2.17 (0.50–9.33) | 1.61 | 0.3 |
DAH | 1.09 (0.30–3.99) | 0.72 | 0.9 |
ILD | 0.92 (0.25–3.35) | 0.61 | 0.9 |
Alb | 1.00 (0.89–1.12) | 0.06 | 0.95 |
Scr | 1.003 (1.001–1.005) | 0.001 | 0.01 |
HBG | 0.99 (0.96–1.01) | 0.01 | 0.26 |
WBC | 0.96 (0.77–1.20) | 0.11 | 0.7 |
CRP | 0.99 (0.97–1.01) | 0.01 | 0.24 |
